Literature DB >> 3903074

Measurement of glomerular filtration rate: single injection plasma clearance method without urine collection.

C D Russell, P G Bischoff, F N Kontzen, K L Rowell, M V Yester, L K Lloyd, W N Tauxe, E V Dubovsky.   

Abstract

Glomerular filtration rate (GFR) can be calculated from the plasma clearance of any of several radiopharmaceuticals that are excreted by glomerular filtration. Simplified methods have been proposed that require only one or two plasma samples in lieu of a more complete clearance curve. We examined the error introduced by this simplification. Forty patients were studied using a dual-isotope technique employing [99mTc]DTPA and [169Yb]DTPA, obtaining eight plasma samples for each clearance curve at intervals from 10 to 240 min after injection. Data were fit to several empirical or semiempirical formulae and also to a two-compartment computer model that permitted GFR estimation from only one or two data points. The computer model gave good fit, but so did several simpler methods. The error that results from replacing the complete clearance curve by a single 3-hr sample was about 8 ml/min (residual s.d.). By using two samples (at 1 and 3 hr), the error could be reduced to 4 ml/min. Recommended one- and two-sample methods are presented.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3903074

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  29 in total

Review 1.  Quantification of renal haemodynamics with radionuclides.

Authors:  A M Peters
Journal:  Eur J Nucl Med       Date:  1991

Review 2.  Methods of assessing renal function.

Authors:  Guido Filler; Abeer Yasin; Mara Medeiros
Journal:  Pediatr Nephrol       Date:  2013-02-17       Impact factor: 3.714

3.  Determination of the technetium-99m mercaptoacetyltriglycine plasma clearance in children by means of a single blood sample: a multicentre study. The Paediatric Task Group of the EANM.

Authors:  A Piepsz; I Gordon; K Hahn; J Kolinska; J Kotzerke; R Sixt
Journal:  Eur J Nucl Med       Date:  1993-03

4.  Tikhonov adaptively regularized gamma variate fitting to assess plasma clearance of inert renal markers.

Authors:  Carl A Wesolowski; Richard C Puetter; Lin Ling; Paul S Babyn
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-09-24       Impact factor: 2.745

5.  Specific efficacy of peptide receptor radionuclide therapy with (177)Lu-octreotate in advanced neuroendocrine tumours of the small intestine.

Authors:  Amir Sabet; Kristina Dautzenberg; Torjan Haslerud; Anas Aouf; Amin Sabet; Birgit Simon; Karin Mayer; Hans-Jürgen Biersack; Samer Ezziddin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-03-26       Impact factor: 9.236

6.  Long-term results of pediatric liver transplantation in a combined pediatric and adult transplant program.

Authors:  Paul R Atkison; B Catherine Ross; Sandy Williams; John Howard; John Sommerauer; Douglas Quan; William Wall
Journal:  CMAJ       Date:  2002-06-25       Impact factor: 8.262

7.  Estimation of glomerular filtration rate using chromium-51 ethylene diamine tetra-acetic acid and technetium-99m diethylene triamine penta-acetic acid.

Authors:  A Biggi; A Viglietti; M C Farinelli; C Bonada; G Camuzzini
Journal:  Eur J Nucl Med       Date:  1995-06

8.  A new principle to normalize plasma concentrations allowing single-sample clearance determinations in both children and adults.

Authors:  B Bubeck; R Piepenburg; U Grethe; B Ehrig; K Hahn
Journal:  Eur J Nucl Med       Date:  1992

9.  Accurate assessment of long-term nephrotoxicity after peptide receptor radionuclide therapy with (177)Lu-octreotate.

Authors:  Amir Sabet; Khaled Ezziddin; Ulrich-Frank Pape; Karl Reichman; Torjan Haslerud; Hojjat Ahmadzadehfar; Hans-Jürgen Biersack; James Nagarajah; Samer Ezziddin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-06       Impact factor: 9.236

10.  Outcome and toxicity of salvage therapy with 177Lu-octreotate in patients with metastatic gastroenteropancreatic neuroendocrine tumours.

Authors:  Amir Sabet; Torjan Haslerud; Ulrich-Frank Pape; Amin Sabet; Hojjat Ahmadzadehfar; Frank Grünwald; Stefan Guhlke; Hans-Jürgen Biersack; Samer Ezziddin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-13       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.